It targets fibroblast-activation protein (FAP) on cancer-associated fibroblasts in tumor stroma and DR5 on tumor cells, again demonstrating the capacity of BATs to induce bystander cytotoxicity (Fig. 2b) [73]. The gene discussed is FAP; the disease is neoplasm.